C Rodrigo - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

C Rodrigo

Showing results (221-230 of 223) with videos related to

Pageof 23

Sort By:

You have reached the last page of results.This site can display upto 223 results.

Journal of Medicinal Chemistry|January 30, 2026

Discovery of AZD9750, an Orally Bioavailable Androgen Receptor Degrader for the Treatment of Prostate CancerJames S Scott, Laura Evans, Peter C Astles, et al.

Nature Communications|March 25, 2026

A dihydrouracil CRBN ligand mitigates IMiD associated safety liabilities in heterobifunctional targeted protein degraderMonica C Rodrigo-Brenni, Jasper C Komen, Ghaith M Hamza, et al.

Anales De Pediatria (Barcelona, Spain : 2003)|January 9, 2009

[Family impact of rotavirus gastroenteritis in children under two years]F Giménez Sánchez, A Delgado Rubio, F Martinón Torres, et al.

Pageof 23

Search research articles

Showing results (221-230 of 223) with videos related to

Sort By:

Pageof 23

You have reached the last page of results.This site can display upto 223 results.

Journal of Medicinal Chemistry|January 30, 2026

Discovery of AZD9750, an Orally Bioavailable Androgen Receptor Degrader for the Treatment of Prostate CancerJames S Scott, Laura Evans, Peter C Astles, et al.

Nature Communications|March 25, 2026

A dihydrouracil CRBN ligand mitigates IMiD associated safety liabilities in heterobifunctional targeted protein degraderMonica C Rodrigo-Brenni, Jasper C Komen, Ghaith M Hamza, et al.

Anales De Pediatria (Barcelona, Spain : 2003)|January 9, 2009

[Family impact of rotavirus gastroenteritis in children under two years]F Giménez Sánchez, A Delgado Rubio, F Martinón Torres, et al.

Pageof 23